INTRODUCTION
Medical science in general and therapeutics in particular is undergoing rapid change and the tremendous growth of the pharmaceutical industry has led to the production of many drugs. This makes it complicated for the physician to prescribe drugs rationally. There is an increasing concern regarding inappropriate, irrational, or sometimes even harmful prescribing patterns. 1 There is a lot of evidence from observational or experimental studies that, eligible patients are not always prescribed the medicines indicated for their condition. On the other side, there is also evidence about over and misuse of pharmaceutical products. A lot of research is trying to analyze and to understand the factors which influence physician prescribing decisions and practice. Thus, it is important to follow the recommended optimal and established drug prescription guidelines for the benefit of the patient as well as society. 2 There are several factors which influence the prescribing behaviour of physicians. Some factors are modifiable and some others are non-modifiable. The non-modifiable factors do not offer any opportunity for any improvements in prescribing behaviour. For example, the age and sex of the physician or the patient, the type of disease state, the socio-economic characteristics of the practicing area or the reimbursement status of therapy. 3, 4 On the other hand, there are factors which can be influenced and in turn cause a modification to the prescribing behaviour of physicians. Such modifiable factors may be the training and the experience of the physician, various social factors, the number of practitioners in a particular place, the type of environment and others. cost to them". 9 In order to prevent serious health risks and socio-economic burden to the patient, WHO has given the Guide to Good Prescribing, which gives a guidance for a structured problem-solved six-step process in choosing and prescribing a suitable drug for an individual patient, i.e., P-drug concept. P-drug referred to as "Preferred" or "Particular" or "Personal" drug is the drug chosen by the physician for a particular disease to treat it in a cost effective manner. 10 The idea was to make physicians familiar with few P-drug chosen from national essential drug list, based on efficacy, safety, suitability, and cost, with regard to the population they come across.
11
This study is conducted to assess the awareness and pattern of P-drug selection among rural general practitioners for medical conditions routinely encountered in general practice.
METHODS
50 General Practitioners in Tumakuru district were given anonymous proformas for selection of P-drugs for common conditions like Diabetes mellitus, Hypertension, URTI, Peptic ulcer. The proforma designed had the following headings: Diagnosis, Specification of the therapeutic objective, Listing of effective group of drugs, and Selection of an effective drug based on safety, affordability, need, and efficacy (SANE criteria). The physicians were requested to fill the proforma. Data was analyzed using descriptive analysis and results were expressed as percentages.
RESULTS
Out of 50, Forty one general practitioners (82%) responded by completing the proformas. Seventeen (34%) of them were aware of the concept of P-drug selection. In mild to moderate hypertension, beta blockers (37%), ACE inhibitors (29%), Amlodipine (15%), and thiazides (13%) were most commonly preferred as shown in Figure 1 . In uncomplicated diabetes, Metformin (27%), sulfonylureas (21%) and their combination (43%) were preferred as oral antidiabetic agents and are shown in Figure 2 . Ampicillin (28%), Ciprofloxacin (23%), Erythromycin (16%) and Cotrimoxazole (15%) were the preferred antibiotics for upper respiratory tract infections other than symptomatic treatment and is shown in Figure 3 . 
DISCUSSION
In the present study, though the majorities of clinicians seem to be aware of and prescribed essential medicines (EM), but surprisingly none of them was able to correctly quantify the drug/drug combinations. The findings are similar to the previous study conducted by Mahajan, et al. 12 Availability of numerous drugs has lead to an era of "drug explosion". The global drug scenario can thus be considered as "therapeutic jungle". This may lead to irrational prescriptions. Understanding the concept of Pdrugs is essential for rational use of drugs which includes the right drug, given to the right patient, in the right dosage, at the right cost. Rational use of medicines contributes to high-quality health care, while irrational use leads to health hazards and wastage of resources that are already insufficient in the majority of health care systems. 13 P-drugs differ from country to country and between doctors due to varying availability and cost of drugs, different national formularies and essential drug lists, medical culture and individual interpretation of information. P-drug selection must not depend on aggressive pharmaceutical marketing as the latest or the most expensive drug may not be the most efficacious and safe one. As evident from the present study, older drugs are preferred as they are cost effective. Newer drugs are less prescribed probably due to lack of information, access and high cost. Concept of P-drug is a relatively new addition to the medical curriculum; hence, most of the senior clinicians may not be aware about it. However, even among junior residents, percentage of practicing P-drug is less though they were exposed to this in their pharmacology curriculum during MBBS.
14 This indicates that the P-drug concept has remained confined to pharmacology and has not become popular among clinicians. This can be considered as a major cause of errors in prescribing with its adverse consequences subsequently. [15] [16] [17] Involvement of clinicians is vital if the P-drug concept is to succeed. A problem-based learning session for teachers in medical colleges needs to be organized. 
